Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 22, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tim Anderson Downgraded (ABBV) to Hold on, Feb 22nd, 2023
Tim Anderson of Wolfe Research, Downgraded "AbbVie Inc." (ABBV) to Hold on, Feb 22nd, 2023.
Tim has made no other calls on ABBV in the last 4 months.
There are 14 other peers that have a rating on ABBV. Out of the 14 peers that are also analyzing ABBV, 7 agree with Tim's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Risinger of "SVB Leerink" Upgraded from Sell to Hold and Increased Target to $153 on, Friday, February 10th, 2023
- Navin Jacob of "UBS" Maintained at Hold with Increased Target to $152 on, Friday, February 10th, 2023
- Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $154 on, Friday, February 10th, 2023
- Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $165 on, Wednesday, December 14th, 2022
- Navaan Ty of "Exane BNP Paribas" Initiated at Hold and Held Target at $169 on, Thursday, December 8th, 2022
- Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Tuesday, November 8th, 2022
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $155 on, Monday, October 31st, 2022
These are the ratings of the 7 analyists that currently disagree with Tim
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $163 on, Friday, February 10th, 2023
- Terence Flynn of "Morgan Stanley" Maintained at Buy with Decreased Target to $178 on, Friday, February 10th, 2023
- Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $180 on, Thursday, February 9th, 2023
- Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Increased Target to $165 on, Thursday, February 9th, 2023
- Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $167 on, Monday, February 6th, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $182 on, Tuesday, December 6th, 2022
- Trung Huynh of "Credit Suisse" Initiated at Buy and Held Target at $170 on, Friday, November 18th, 2022
